TrkA overexpression enhances growth and metastasis of breast cancer cells
暂无分享,去创建一个
R. Toillon | H. Hondermarck | B. Foveau | E. Adriaenssens | S. Meignan | C. Lagadec | E. Vanhecke | X. Bourhis | R. Romon | B. Oxombre | Elsa Vanhecke | Chann Lagadec | Rodrigue Romon
[1] Kedar S Vaidya,et al. BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation , 2008, Clinical & Experimental Metastasis.
[2] Kedar S Vaidya,et al. BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process. , 2008, The American journal of pathology.
[3] H. Hondermarck,et al. Nerve growth factor is a potential therapeutic target in breast cancer. , 2008, Cancer research.
[4] D. Peeper,et al. Critical role for TrkB kinase function in anoikis suppression, tumorigenesis, and metastasis. , 2007, Cancer research.
[5] Robert D. Cardiff,et al. Insights from transgenic mouse models of ERBB2-induced breast cancer , 2007, Nature Reviews Cancer.
[6] L. Reichardt,et al. Neurotrophin-regulated signalling pathways , 2006, Philosophical Transactions of the Royal Society B: Biological Sciences.
[7] C. Cordon-Cardo,et al. Autocrine PDGFR signaling promotes mammary cancer metastasis. , 2006, The Journal of clinical investigation.
[8] N. Kyprianou,et al. Anoikis and survival connections in the tumor microenvironment: is there a role in prostate cancer metastasis? , 2005, Cancer research.
[9] R. Bachelder,et al. Non-Angiogenic Functions of VEGF in Breast Cancer , 2005, Journal of Mammary Gland Biology and Neoplasia.
[10] R. Kramer,et al. Adhesion-mediated squamous cell carcinoma survival through ligand-independent activation of epidermal growth factor receptor. , 2004, The American journal of pathology.
[11] I. Screpanti,et al. TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma. , 2004, Cancer cell.
[12] D. Peeper,et al. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB , 2004, Nature.
[13] F. Akiyama,et al. Efficacy and Safety of Trastuzumab as a Single Agent in Heavily Pretreated Patients with Her-2/NEU-Overexpressing Metastatic Breast Cancer , 2004, Tumori.
[14] H. Hondermarck,et al. Nerve growth factor overexpression and autocrine loop in breast cancer cells , 2003, Oncogene.
[15] J. Nesland,et al. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[16] D. Ribatti,et al. Nerve growth factor–endothelial cell interaction leads to angiogenesis in vitro and in vivo , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] S. Hirohashi,et al. Critical involvement of the phosphatidylinositol 3-kinase/Akt pathway in anchorage-independent growth and hematogeneous intrahepatic metastasis of liver cancer. , 2002, Cancer research.
[18] Lyndsay N Harris,et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] F. Amenta,et al. Neurotrophins and neurotrophin receptors in human lung cancer. , 2001, American journal of respiratory cell and molecular biology.
[20] F. Révillion,et al. Expression of nerve growth factor receptors and their prognostic value in human breast cancer. , 2001, Cancer research.
[21] J. Peyrat,et al. Nerve Growth Factor Stimulates Proliferation and Survival of Human Breast Cancer Cells through Two Distinct Signaling Pathways* , 2001, The Journal of Biological Chemistry.
[22] P. Lazarovici,et al. Tamoxifen inhibits nerve growth factor-induced proliferation of the human breast cancerous cell line MCF-7. , 2001, Cancer research.
[23] M. Mesiti,et al. Nerve Growth Factor Receptor Immunoreactivity in Breast Cancer Patients , 2001, Cancer investigation.
[24] A. Weeraratna,et al. Rational basis for Trk inhibition therapy for prostate cancer , 2000, The Prostate.
[25] G. Barrett. The p75 neurotrophin receptor and neuronal apoptosis , 2000, Progress in Neurobiology.
[26] S. Ménard,et al. Nerve Growth Factor Cooperates with p185 HER2 in Activating Growth of Human Breast Carcinoma Cells* , 2000, The Journal of Biological Chemistry.
[27] H. Friess,et al. Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] S. Baylin,et al. Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[29] Bull,et al. Expression of nerve growth factor receptors in cutaneous inflammation , 1998, The British journal of dermatology.
[30] M. Chao. The p75 neurotrophin receptor. , 1994, Journal of neurobiology.
[31] A. Selman,et al. Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer. , 2007, Gynecologic oncology.
[32] J. Nesland,et al. Altered Expression and Activation of the Nerve Growth Factor Receptors TrkA and p75 Provide the First Evidence of Tumor Progression to Effusion in Breast Carcinoma , 2004, Breast Cancer Research and Treatment.
[33] 中西 一彰. Critical involvement of the phosphatidylinositol 3-kinase/Akt pathway in anchorage-independent growth and hematogeneous intrahepatic metastasis of liver cancer , 2003 .
[34] J. Mukai,et al. Nerve growth factor-dependent regulation of NADE-induced apoptosis. , 2003, Vitamins and hormones.
[35] S. Frisch,et al. Anoikis mechanisms. , 2001, Current opinion in cell biology.
[36] P. Lazarovici,et al. Advances in Brief Tamoxifen Inhibits Nerve Growth Factor-induced Proliferation of the Human Breast Cancerous Cell Line MCF-71 , 2001 .